Melanie Sena is community editor of Pharmaceutical Technology.
Octapharma and Pfizer form an agreement for the future marketing and commercialization of human prothrombin complex concentrate.
GSK forms the Oncology Clinical and Translational Consortium, a scientific research network comprised of six international cancer centers.
Johnson&Johnson will open a network of partnering offices across the UK.
Bristol-Myers Squibb has elected Thomas Lynch, Jr., MD to its board of directors.
BioWa and Lonza have entered into a licensing agreement with MedImmune for cell line technology.
LSNE appoints Shawn Cain as COO, a new position within the company.
Pure MHC and Catalent sign an agreement to develop RL21A using Catalent's GPEx technology.
GSK and Amicus Therapeutics revise Fabry agreement entered into in July 2012.
Almac releases an enhanced third-party logistics customer billing application.